BE880282A - 4,1-benzoxazepines et 4,1-benzothiazepines - Google Patents

4,1-benzoxazepines et 4,1-benzothiazepines

Info

Publication number
BE880282A
BE880282A BE0/198307A BE198307A BE880282A BE 880282 A BE880282 A BE 880282A BE 0/198307 A BE0/198307 A BE 0/198307A BE 198307 A BE198307 A BE 198307A BE 880282 A BE880282 A BE 880282A
Authority
BE
Belgium
Prior art keywords
benzoxazepines
benzothiazepines
Prior art date
Application number
BE0/198307A
Other languages
English (en)
Inventor
K Hirai
S Matsutani
T Ishiba
I Makino
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of BE880282A publication Critical patent/BE880282A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02—Seven-membered rings
    • C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D267/14—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/36—Seven-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
BE0/198307A 1978-11-27 1979-11-27 4,1-benzoxazepines et 4,1-benzothiazepines BE880282A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14694978A JPS5572177A (en) 1978-11-27 1978-11-27 4,1-benzoxazepine or 4,1-benzothiazepine

Publications (1)

Publication Number Publication Date
BE880282A true BE880282A (fr) 1980-03-17

Family

ID=15419209

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/198307A BE880282A (fr) 1978-11-27 1979-11-27 4,1-benzoxazepines et 4,1-benzothiazepines

Country Status (21)

Country Link
US (2) US4297280A (fr)
JP (1) JPS5572177A (fr)
AR (1) AR227879A1 (fr)
AU (1) AU533517B2 (fr)
BE (1) BE880282A (fr)
CA (1) CA1127639A (fr)
CH (1) CH642647A5 (fr)
DD (1) DD147360A5 (fr)
DE (1) DE2947773A1 (fr)
DK (1) DK500179A (fr)
ES (4) ES8102106A1 (fr)
FR (1) FR2442239A1 (fr)
GB (1) GB2046729B (fr)
HU (1) HU179589B (fr)
IT (1) IT1165246B (fr)
MX (1) MX6217E (fr)
NL (1) NL7908596A (fr)
NZ (1) NZ192092A (fr)
SE (1) SE7909751L (fr)
SU (2) SU936815A3 (fr)
ZA (1) ZA796040B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2480751A1 (fr) * 1980-04-18 1981-10-23 Shionogi & Co 4,1-benzoxazepines et leur utilisation comme produits pharmaceutiques pour le systeme nerveux central

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5759893A (en) * 1980-09-29 1982-04-10 Shionogi & Co Ltd 4,1-benzoxazepin derivative
CA1211437A (fr) * 1981-08-12 1986-09-16 Rene Borer Benzazepines
US4590187A (en) * 1983-11-17 1986-05-20 The Upjohn Company Phospholipase A2 inhibition using 4,1-benzoxazepine-2-(3H)-ones
US4897392A (en) * 1989-07-03 1990-01-30 Hoechst-Roussel Pharmaceuticals, Inc. 4H-indolo(1,2-d)(1,2,4)triazolo(4,3-A)(1,4)benzodiazepines
US5552399A (en) * 1994-11-02 1996-09-03 Janssen Pharmaceutica N.V. Substituted tetracyclic azepine derivatives
US6063921A (en) * 1997-11-20 2000-05-16 Pharm-Eco Laboratories, Inc. Synthesis of 11-aryl-5,6-dihydro-11H-dibenz[b,e]azepines
RU2266906C1 (ru) * 2004-04-29 2005-12-27 Общество с ограниченной ответственностью "Исследовательский Институт Химического Разнообразия" (ООО "Исследовательский Институт Химического Разнообразия") Анелированные карбамоилазагетероциклы, способы их получения (варианты), фармацевтическая композиция, фокусированная библиотека

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1090611A (en) * 1963-05-22 1967-11-08 Lepetit Spa 4,1-benzoxazepine derivatives
DE1545639A1 (de) * 1965-11-19 1969-08-07 Boehringer Sohn Ingelheim Verfahren zur Herstellung von Derivaten des 3,5-Dihydro-4,1-Benzothiazepin-2[1 H]-ons
BE793629A (fr) * 1972-01-03 1973-07-03 Upjohn Co Nouveaux derives de benzodiazepines et leur preparation
JPS5084590A (fr) * 1973-11-28 1975-07-08
US4000151A (en) * 1974-09-11 1976-12-28 The Upjohn Company Triazolyl benzophenone compounds
US3933816A (en) * 1974-09-12 1976-01-20 The Upjohn Company 3-(Substituted aminomethyl)-7-substituted-3,5-dihydro-as-triazino[4,3-a][1,5]benzodiazepines
US3966756A (en) * 1975-04-07 1976-06-29 American Cyanamid Company Substituted dibenzo[b,f]tetrazolo[1,5-d][1,4]-oxazepines
US4246270A (en) * 1976-05-26 1981-01-20 E. I. Du Pont De Nemours And Company 3-Fluorobenzodiazepines and compositions and uses thereof
US4207322A (en) * 1975-11-04 1980-06-10 Deutsche Gold- Und Silber-Scheideanstalt Vormals Roessler 6-Aryl-s-triazolo-(4,3-alpha)-pyrido-(2,3-f)-(1,4)-diazepines
US4180668A (en) * 1977-06-08 1979-12-25 The Upjohn Company Piperidino-4H-s-triazolo[4,3-a][1,4]benzodiazepines
JPS54119499A (en) * 1978-03-09 1979-09-17 Shionogi & Co Ltd Triazolobenzodiazepin derivative

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2480751A1 (fr) * 1980-04-18 1981-10-23 Shionogi & Co 4,1-benzoxazepines et leur utilisation comme produits pharmaceutiques pour le systeme nerveux central

Also Published As

Publication number Publication date
AR227879A1 (es) 1982-12-30
DD147360A5 (de) 1981-04-01
ES493759A0 (es) 1981-08-01
US4297280A (en) 1981-10-27
US4341704A (en) 1982-07-27
HU179589B (en) 1982-11-29
ES493761A0 (es) 1981-08-01
SU1005660A3 (ru) 1983-03-15
NL7908596A (nl) 1980-05-29
DE2947773A1 (de) 1980-06-04
SU936815A3 (ru) 1982-06-15
ES486328A0 (es) 1980-12-16
ES8102106A1 (es) 1980-12-16
ES493760A0 (es) 1981-08-01
NZ192092A (en) 1984-07-31
JPS5572177A (en) 1980-05-30
ZA796040B (en) 1980-10-29
MX6217E (es) 1984-12-21
FR2442239B1 (fr) 1983-07-01
GB2046729B (en) 1983-01-26
ES8106731A1 (es) 1981-08-01
ES8106729A1 (es) 1981-08-01
AU5299379A (en) 1980-05-29
IT7969279A0 (it) 1979-11-26
IT1165246B (it) 1987-04-22
CH642647A5 (de) 1984-04-30
CA1127639A (fr) 1982-07-13
JPS6231719B2 (fr) 1987-07-09
DK500179A (da) 1980-05-28
FR2442239A1 (fr) 1980-06-20
ES8106730A1 (es) 1981-08-01
GB2046729A (en) 1980-11-19
AU533517B2 (en) 1983-12-01
SE7909751L (sv) 1980-05-28

Similar Documents

Publication Publication Date Title
NL7903029A (nl) 2'deoxy-5-(2-halogeenvinyl)-uridines.
IT1193190B (it) 2,3,4,5-tetraidro-1h-3-benzazepine mercapto-sostituito
ATE202T1 (de) 2-cycloalkyl-pyrimidin(5)
FI792430A (fi) Modificerade graespollen-antigener
FI793663A (fi) 1,2,4,5-tetra-alkyl-4-arylpiperidiner
SE7803411L (sv) 2,6-dialkoxibensamider
IT1114278B (it) Agnete chelante e chelati
TR20548A (tr) 1,2,3-tiyadiyazel-5-yil uerelerin imalline mahsus usul
BE880282A (fr) 4,1-benzoxazepines et 4,1-benzothiazepines
LU81071A1 (fr) Vitrai 12
FI790581A (fi) Katodisk loesning av kobolt (3)-hydroxid
ATA457479A (de) Stabilisietes 1,1,1-trichloraethan
NL7903973A (nl) 1,2,4-triazolidinonen-3 en thionen-3.
FI790141A (fi) 2 6-dinitrobensenaminer
ATA457579A (de) Stabilisiertes 1,1,1-trichloraethan
FI802904A (fi) 15-sulfonamidprostaglandinderivat
NL7900005A (nl) 11-alkanoyl-4"-desoxy-4"-isonitrilo-oleandomycine-deri- vaten.
BE875273A (fr) 0-carbamoyloximes de 2,3-dihydro-4h-1-benzo-pyranne-4-ones
FI791423A (fi) Foerfarande foer loesningsvaermebehandling av 6201 aluminiumlegering
FI791466A (fi) Foerfarande foer framstaellning av alfa-(4(4-klorbenzoylamino-etyl)-fenoxi)-smoersyra
BE883295A (fr) 6,7-secoergolines
FI790639A (fi) 1-oxa-4-aza-2,6 disilacyklohexaner dessas framstaellning och deras anvaendning saosom muskelrelaxanter
NL7904266A (nl) Antrachinonverbindingen en de mengsels daarvan.
DK136379A (da) 4,6-dihalogensteroider
FI791139A (fi) Nytt framstaellningsfoerfarande av 4-substituerade 1,2-difenyl-3,5-dioxopyrazolidiner

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: SHIONOGI & CO. LTD

Effective date: 19851130